Hackensack University Medical Center Offers an Innovative New Screening Option for Patients at High Risk for Pancreatic Cancer
Jubilant Therapeutics Inc. administre une dose au premier patient de l’essai de phase I/II évaluant le JBI-802, un inhibiteur double de LSD1 et de HDAC6, chez des patients atteints de tumeurs solides avancées Deutschland – Deutsch USA – English France – Français
PBF Logistics Declares Quarterly Distribution of $0.30 per Unit and Announces First Quarter 2022 Earnings Results
Bausch + Lomb Will Present New Scientific Data and Analyses on Products and Pipeline Programs During the Association for Research in Vision and Ophthalmology Meeting
LAWSUIT AGAINST DUNKIN’ BELIEVED TO BE FIRST ALLEGING LINK BETWEEN SEVERE CUSTOMER BURNS AND DEFECTIVE PAPER COFFEE-CUP CARRIER
Dstillery Launches ID-free Custom AI™ to Help Brands Reach Their Audiences Without Third-Party Cookies
Introducing Tequila Zarpado Reposado, New Small-Batch Reposado Tequila Handcrafted by Family Distillery
Bausch Health Enters Into Arrangement Agreement with Bausch + Lomb Corporation in Connection with Previously Announced Proposed Separation
